AiRato Inc. Wins Second Place at Singapore Healthcare Pitch Japan Selection! Bringing Japan's Radiation Therapy AI to the World
AiRato Inc. won second place (semi-grand prize) at the Singapore Healthcare Pitch Japan Selection. The company's radiation therapy AI technology was evaluated against international standards, and its suitability for clinical trials in Singapore hospitals was recognized.
📋 Article Processing Timeline
- 📰 Published: June 4, 2026 at 01:06
- 🔍 Collected: June 3, 2026 at 16:20
- 🤖 AI Analyzed: June 7, 2026 at 00:31 (80h 11m after Collected)
AiRato Inc. (Headquarters: Sendai City, Miyagi Prefecture; Co-CEOs: Yuri Kimura and Tomoyuki Kakutani), a company developing AI for radiation therapy, won the second-place semi-grand prize at the 'CHISEL Healthcare InnoMatch 2026 Singapore Healthcare Pitch Japan Selection' held on Friday, May 29, 2026, at the Nihonbashi Life Science Hub in Tokyo, organized by INDEE Japan.
This competition was the official Japanese selection for an international pitch contest organized by CHISEL, Singapore's public healthcare innovation promotion agency. A total of 19 healthcare startups from across Japan participated.
*CHISEL: Centre of Healthcare Innovation Start-Up Enterprise Link
The event brought together solutions that use cutting-edge technology to break through on-site challenges such as labor shortages, workload, and improving the quality of medical care. Judging was conducted according to the same international standards used in Singapore, rigorously evaluating whether the technology and business were globally viable. AiRato was awarded for its suitability for clinical trials in Singaporean hospitals, among other factors.
■ About AiRato's Initiatives
AiRato is working to innovate 'treatment planning,' a key element of radiation therapy.
- Responding to the increasing number of cancer patients: Delivering advanced treatment to more patients with limited medical resources.
- Reducing the burden on medical professionals: Significantly shortening the time required for conventional treatment planning and alleviating workload.
- Standardizing treatment accuracy: Reducing disparities in treatment outcomes between medical institutions through AI-driven standardization.
Issues such as labor shortages and medical disparities are common not only in Japan but across Asia. AiRato will continue to develop and provide AI-powered radiation therapy planning support software originating from Japan that changes clinical practice.
■ Comment from AiRato Co-CEO Tomoyuki Kakutani
"In the field of radiation therapy, we ourselves have felt the challenges of a shortage of specialized personnel and regional differences in treatment. These challenges are common to Singapore and other Asian countries. It is encouraging to have the potential of our technology, cultivated in Japan, to be useful across borders recognized here. Our desire is to deliver high-quality treatment to all patients who need radiation therapy, regardless of where they live. This event reaffirmed that the same aspiration exists in Singapore and other parts of Asia. We will continue to aim for a future where more people can access high-quality radiation therapy."
[About AiRato Inc.]
AiRato is a medical innovation company founded by medical professionals and researchers who understand the realities of cancer treatment, aiming to change the future of cancer treatment with AI technology. Starting from the on-site challenges of radiation therapy, a type of cancer treatment, the company develops and provides medical AI products that are continuously used in clinical settings.
In the highly specialized field of radiation therapy planning, the company aims to support the quality of medical care and the sustainability of clinical practice. The company's corporate slogan, 'AIがある、革新／AiRato with Heart,' embodies its focus on each individual patient beyond the technology.
Company Name: AiRato Inc.
Locations
Head Office: T-Biz, 6-6-40 Aoba, Aramaki Aza Aoba, Aoba-ku, Sendai City, Miyagi Prefecture
Tokyo Office: 16F, Sumitomo Fudosan Shiba Park Tower, 2-11-1 Shibakoen, Minato-ku, Tokyo
Co-CEOs: Yuri Kimura, Tomoyuki Kakutani
Established: March 2022
Business: Development and provision of AI-powered radiation therapy planning support software
This competition was the official Japanese selection for an international pitch contest organized by CHISEL, Singapore's public healthcare innovation promotion agency. A total of 19 healthcare startups from across Japan participated.
*CHISEL: Centre of Healthcare Innovation Start-Up Enterprise Link
The event brought together solutions that use cutting-edge technology to break through on-site challenges such as labor shortages, workload, and improving the quality of medical care. Judging was conducted according to the same international standards used in Singapore, rigorously evaluating whether the technology and business were globally viable. AiRato was awarded for its suitability for clinical trials in Singaporean hospitals, among other factors.
■ About AiRato's Initiatives
AiRato is working to innovate 'treatment planning,' a key element of radiation therapy.
- Responding to the increasing number of cancer patients: Delivering advanced treatment to more patients with limited medical resources.
- Reducing the burden on medical professionals: Significantly shortening the time required for conventional treatment planning and alleviating workload.
- Standardizing treatment accuracy: Reducing disparities in treatment outcomes between medical institutions through AI-driven standardization.
Issues such as labor shortages and medical disparities are common not only in Japan but across Asia. AiRato will continue to develop and provide AI-powered radiation therapy planning support software originating from Japan that changes clinical practice.
■ Comment from AiRato Co-CEO Tomoyuki Kakutani
"In the field of radiation therapy, we ourselves have felt the challenges of a shortage of specialized personnel and regional differences in treatment. These challenges are common to Singapore and other Asian countries. It is encouraging to have the potential of our technology, cultivated in Japan, to be useful across borders recognized here. Our desire is to deliver high-quality treatment to all patients who need radiation therapy, regardless of where they live. This event reaffirmed that the same aspiration exists in Singapore and other parts of Asia. We will continue to aim for a future where more people can access high-quality radiation therapy."
[About AiRato Inc.]
AiRato is a medical innovation company founded by medical professionals and researchers who understand the realities of cancer treatment, aiming to change the future of cancer treatment with AI technology. Starting from the on-site challenges of radiation therapy, a type of cancer treatment, the company develops and provides medical AI products that are continuously used in clinical settings.
In the highly specialized field of radiation therapy planning, the company aims to support the quality of medical care and the sustainability of clinical practice. The company's corporate slogan, 'AIがある、革新／AiRato with Heart,' embodies its focus on each individual patient beyond the technology.
Company Name: AiRato Inc.
Locations
Head Office: T-Biz, 6-6-40 Aoba, Aramaki Aza Aoba, Aoba-ku, Sendai City, Miyagi Prefecture
Tokyo Office: 16F, Sumitomo Fudosan Shiba Park Tower, 2-11-1 Shibakoen, Minato-ku, Tokyo
Co-CEOs: Yuri Kimura, Tomoyuki Kakutani
Established: March 2022
Business: Development and provision of AI-powered radiation therapy planning support software
FAQ
Where is AiRato Inc. headquartered?
In Aoba-ku, Sendai City, Miyagi Prefecture.
When and where did the award take place?
On May 29, 2026, in Nihonbashi, Tokyo.
What is AiRato's technology?
AI-powered software that supports radiation therapy treatment planning.